Key Events This Week
7 Sep: New 52-week high at Rs.221.85
8 Sep: All-time high reached at Rs.226.9 with exceptional volume surge
9 Sep: Sharp price correction amid market weakness
11 Sep: Week closes at Rs.211.25, down 1.38%

Piramal Pharma Ltd is Rated Sell by MarketsMOJO
2026-09-10 10:10:03Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Bullish Momentum
2026-09-08 12:00:09Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks on 8 September 2026, registering a remarkable volume surge that coincided with a notable price appreciation. Despite a broader market downturn, the pharmaceutical company outperformed its sector and benchmark indices, signalling heightened investor interest and potential accumulation.
Read full news article
Broad-Based Technical Strength Lifts Piramal Pharma Ltd to 52-Week High of Rs 226.9
2026-09-08 10:05:07Surging past its previous peaks, Piramal Pharma Ltd touched a fresh 52-week high of Rs 226.9 on 8 Sep 2026, marking a significant milestone in its price momentum. This advance comes amid a broader market downturn, underscoring the stock's resilience and technical strength.
Read full news article
Piramal Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility
2026-09-08 08:08:57Piramal Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend despite mixed monthly signals and a challenging broader market environment.
Read full news article









